Effect of Myofacial Release vs. Eccentric Resistance on Pain, ROM and Functional Disability on Achilles Tendonitis

April 6, 2023 updated by: Ayesha Jamil, University of Lahore

Comparative Effect of Myofacial Release With and Without Eccentric Resistance on Pain, Range of Motion and Functional Disability in Patients With Achilles Tendonitis

Achilles tendinitis is a common condition that cause pain along back of leg near the heal. It is an overuse injury of the Achilles tendon, the band of tissue that connect calf muscles at the back of the lower leg to heel bone. There are number of treatment approaches to relieve pain in Achilles tendonitis . Insufficient literature has discuss the combine effect of myofascial release with eccentric resistance. So the aim of the study is to compare the effect of myofascial release with eccentric resistance and without eccentric resistance on pain , range of motion and functional disability in patient with Achilles tendinitis

Study Overview

Detailed Description

Tendonitis refers to inflammation of a tendon in response to injury or disease. It causes pain, irritation, and swelling, especially following periods of activity. Achilles tendinitis (AT) is a prevalent condition across the lifespan in both active and sedentary people, and can occur in the mid tendon, tendon insertion to the calcaneus and peritendon.

Achilles tendinitis is caused by overuse of the ankle and is closely related to an individuals activity level. In the adult population (21-60 yrs old), the incidence rate is 2.35 persons per 1000. It has been reported in approximately 7%-9% of professional athletes and 6%-18% of regular runners.

People with Achilles tendinitis typically report symptoms of pain and stiffness upon weight bearing after prolonged rest and at the start of physical activity, which reduces as the activity continues . These symptoms lead to impaired performance. In more severe cases, pain and disability can be persistent with functional activities such as walking.

Physical therapists have used different methods to maintain and also to increase joint motion, and prevent deformity and dysfunction resulting from the muscle shortening. The intension of the physical therapist is to lengthen the musculo-tendinous unit, supporting connective tissue and increase the range of motion.

Soft tissue treatments are widely used for AT, but strong scientific evidence to support those treatments is lacking. The literature provides some evidence that heavy pressure and deep massage might have some positive effect on chronic tendonitis by promoting healing.

Eccentric training can be effective in the rehabilitation of patients with Achilles tendonitis. The mechanism behind these results is not clear. However, there is evidence that tendons are able to respond to repeated forces by altering their structure and composition, and, thus, their mechanical properties change

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • The University of Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Both male and female.
  • Age limit 25-50 year.
  • Diagnosed patients by orthopedic surgeon.
  • Achilles tendon symptoms (pain) present in one limb for a minimum of two months.
  • Report having pain rated at least 3 out of 10 on a numerical rating scale (NRS-11).
  • Be able to walk household distances (more than 50 m) without the aid of a walker, crutches or can

Exclusion Criteria:

  • History of Pregnanc.
  • Having history of rheumatoid arthritis or generalized polyarthritis.
  • Pervious history of Achilles tendon rupture or surgery i.e arthrodesis , club foot surgery
  • History of hind foot fracture, or leg-length discrepancy of more than one-half inch.
  • Taken any manual therapy in last 3 month.
  • Contraindication to myofacial releas i.e skin burn or disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Myofascial release

Group A:

This group will receive routine physiotherapy with myofascial release. This protocol will be given for 3 alternative days per week. Each session will be of 45 minutes. Data will be collected at baseline, at 2nd week and at 4th week.

The subject will lye prone on a treatment table. Deep longitudinal massage with the help of both thumbs reinforcing eachother will be given on the subject's calf muscles.
Experimental: eccentric resistance exercise

Group B:

This group will receive routine physiotherapy and myofascial release with eccentric resistance exercise . This protocol will be given for 3 alternative days per week. Each session will be of 60 minutes. Data will be collected at baseline, at 2nd week and at 4th week.

The subject will lying prone on a treatment table. One end of eccentric resistance band will tie around the mid of the foot of indvidual, the other end of the resistance band will be attach to the table and the band is adjusted so that it will tight and there will be no slack present in it. It will provide a smooth eccentric resistance throughout the dorsiflexion range

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: change in pain intensity score will be measured at baseline , at 2nd week , at 4th week
pain intensity will be measured by Numeric Pain Rating Scale
change in pain intensity score will be measured at baseline , at 2nd week , at 4th week
Range of motion
Time Frame: Change in range of motion score will be measured at baseline , at 2nd week , at 4th week
Range of motion will be measured by goniometer
Change in range of motion score will be measured at baseline , at 2nd week , at 4th week
Functional disability
Time Frame: change in Function disability score will be measured at baseline, at 2nd week , at 4th week
Functional disability will be measured by ankle foot disability index
change in Function disability score will be measured at baseline, at 2nd week , at 4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2022

Primary Completion (Actual)

February 28, 2023

Study Completion (Actual)

February 28, 2023

Study Registration Dates

First Submitted

September 19, 2022

First Submitted That Met QC Criteria

September 19, 2022

First Posted (Actual)

September 22, 2022

Study Record Updates

Last Update Posted (Actual)

April 7, 2023

Last Update Submitted That Met QC Criteria

April 6, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Immediately after publication

IPD Sharing Time Frame

Beginning 9 months and ending on 36th month

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendonitis

Clinical Trials on myofascial release

Subscribe